Oct. 31, 2024 — Children who experienced sugar restrictions during their first 1,000 days after conception had up to 35% lower risk of developing type 2 diabetes and as much as 20% less risk of ...

Type 1 diabetes is an autoimmune disease in which the immune system attacks and destroys the cells in the body that produce insulin. The rate of type 1 diabetes is rising worldwide, with the greatest ...

NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced the completion of the ...

Type 1 diabetes (also known as diabetes mellitus) is an autoimmune disease in which immune cells attack and destroy the insulin-producing cells of the pancreas. The loss of insulin leads to the ...

遭遇投资者广泛质疑后，创新药企信达生物（1801.HK）选择了“听劝”——宣布撤回了将子公司部分股权出售给创始人的计划。 11月3日晚间，信达生物公告称，Fortvita与Lostrancos经进一步考虑后，双方同意通过Fortvita与Lostrancos于2024年11月3日订立的终止协议，以终止 ...